本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Trevi Therapeutics Inc.

15.26
+0.24501.63%
成交量:53.60萬
成交額:825.74萬
市值:21.66億
市盈率:-43.36
高:15.57
開:15.38
低:15.21
收:15.01
52周最高:20.22
52周最低:7.97
股本:1.42億
流通股本:1.18億
量比:0.79
換手率:0.45%
股息:- -
股息率:- -
每股收益(TTM):-0.3518
每股收益(LYR):-0.3173
淨資產收益率:-19.66%
總資產收益率:-13.82%
市淨率:6.74
市盈率(LYR):-48.07

資料載入中...

2023/04/11

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/16

重要事件披露

8-K - Current report
2023/03/16

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/11/10

重要事件披露

8-K - Current report
2022/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/07

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/10/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/23

重要事件披露

8-K - Current report
2022/09/19

重要事件披露

8-K - Current report
2022/08/11

重要事件披露

8-K - Current report
2022/08/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/29

重要事件披露

8-K - Current report
2022/06/23

重要事件披露

8-K - Current report